Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
omega-3 fatty acids (Omacor) (1 trial)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Sclerosis (Phase 3)
Trials (1 total)
Trial APIs (1 total)